NTRK fusions identified in pediatric tumors: the frequency, fusion partners, and clinical outcome

X Zhao, C Kotch, E Fox, LF Surrey… - JCO precision …, 2021 - ascopubs.org
PURPOSE Neurotrophic tyrosine receptor kinase (NTRK) fusions have been described as
oncogenic drivers in a variety of tumors. However, little is known about the overall frequency …

[HTML][HTML] NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical Outcome

X Zhao, C Kotch, E Fox, LF Surrey… - JCO Precision …, 2021 - ncbi.nlm.nih.gov
PURPOSE Neurotrophic tyrosine receptor kinase (NTRK) fusions have been described as
oncogenic drivers in a variety of tumors. However, little is known about the overall frequency …

NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical Outcome.

X Zhao, C Kotch, E Fox, LF Surrey… - JCO Precision …, 2021 - europepmc.org
PURPOSE Neurotrophic tyrosine receptor kinase (NTRK) fusions have been described as
oncogenic drivers in a variety of tumors. However, little is known about the overall frequency …

NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical Outcome

X Zhao, C Kotch, E Fox, LF Surrey… - JCO precision …, 2021 - pubmed.ncbi.nlm.nih.gov
Purpose Neurotrophic tyrosine receptor kinase (NTRK) fusions have been described as
oncogenic drivers in a variety of tumors. However, little is known about the overall frequency …

NTRK Fusions Identified in Pediatric Tumors: The Frequency, Fusion Partners, and Clinical Outcome.

X Zhao, C Kotch, E Fox, LF Surrey… - JCO Precision …, 2021 - europepmc.org
PURPOSE Neurotrophic tyrosine receptor kinase (NTRK) fusions have been described as
oncogenic drivers in a variety of tumors. However, little is known about the overall frequency …